TherapeuticsMD (TXMD) Notes Payables (2010 - 2012)

TherapeuticsMD has reported Notes Payables for 3 years, with the latest figure at $3.1 million in Q4 2012.

• For the quarter ending Q4 2012, Notes Payables rose 44.28% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2012 stood at $3.1 million (up 44.28% YoY), and the FY2012 full-year result was $3.1 million, up 44.28% from the prior year.
• Notes Payables for Q4 2012 stood at $3.1 million, roughly flat from $3.1 million in the prior quarter.
• The five-year high for Notes Payables was $3.1 million in Q3 2012, with the low at $99000.0 in Q2 2011.
• Historically, Notes Payables has averaged $1.3 million across 3 years, with a median of $299220.0 in 2012.
• Annual changes were most pronounced in 2011 — Notes Payables jumped 923.81% — and 2012, when it soared 44.28%.
• TherapeuticsMD's Notes Payables stood at $210000.0 in 2010, then jumped by 923.81% to $2.2 million in 2011, then soared by 44.28% to $3.1 million in 2012.
• The last three Notes Payables figures came in at $3.1 million (Q4 2012), $3.1 million (Q3 2012), and $299220.0 (Q2 2012), per Business Quant data.